Table of Contents Author Guidelines Submit a Manuscript
Advances in Medicine
Volume 2014, Article ID 947258, 6 pages
http://dx.doi.org/10.1155/2014/947258
Research Article

Effects of Atorvastatin on Oxidative Stress Biomarkers and Mitochondrial Morphofunctionality in Hyperfibrinogenemia-Induced Atherogenesis

1Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, X5000 Córdoba, Argentina
2Instituto de Investigación en Ciencias de la Salud Humana (IICSHUM), Universidad Nacional de La Rioja, La Rioja, Argentina
3Becaria Secyt, Universidad Nacional de Córdoba, Córdoba, Argentina
4Cátedra de Física Biomédica, Facultad de Ciencias Médicas, Universidad Nacional de La Rioja, F5300 La Rioja, Argentina

Received 23 July 2014; Revised 29 September 2014; Accepted 29 September 2014; Published 23 October 2014

Academic Editor: João Quevedo

Copyright © 2014 María de la Paz Scribano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Okwuosa, P. Greenland, G. L. Burke et al., “Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis,” JACC: Cardiovascular Imaging, vol. 5, no. 2, pp. 144–153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Folsom, K. K. Wu, W. D. Rosamond, A. R. Sharrett, and L. E. Chambless, “Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study,” Circulation, vol. 96, no. 4, pp. 1102–1108, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Prizment, K. E. Anderson, K. Visvanathan, and A. R. Folsom, “Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 2, pp. 297–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Baez, M. Tarán, V. Campana et al., “Marcadores de estrés oxidativo en aterogénesis inducida por hiperfibrinogenemia,” Archivos de Cardiología de México, vol. 79, no. 2, pp. 85–90, 2009. View at Google Scholar
  5. J. L. Martín-Ventura, L. M. Blanco-Colio, J. Muñón et al., “Biomarcadores en la medicina cardiovascular,” Revista Espanola de Cardiologia, vol. 62, no. 6, pp. 677–688, 2009. View at Google Scholar
  6. L. M. Canseco-Ávila, C. Jerjes-Sánchez Díaz, R. Ortiz-López, A. Rojas-Martínez, and D. Guzmán-Ramírez, “Fibrinogen Cardiovascular risk factor or marker?” Archivos de Cardiologia de Mexico, vol. 76, supplement 4, pp. S158–S172, 2006. View at Google Scholar · View at Scopus
  7. M. Moya, V. Campana, A. Gavotto, L. Spitale, J. Simes, and J. Palma, “Simvastatin: pharmacological response in experimental hyperfibrinogenaemias,” Acta Cardiologica, vol. 60, no. 2, pp. 159–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. K. K. Koh, P. C. Oh, and M. J. Quon, “Does reversal of oxidative stress and inflammation provide vascular protection?” Cardiovascular Research, vol. 81, no. 4, pp. 649–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. I. Borissoff, H. M. H. Spronk, and H. T. Cate, “The hemostatic system as a modulator of atherosclerosis,” The New England Journal of Medicine, vol. 364, no. 18, pp. 1746–1760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. C. Montezano and R. M. Touyz, “Reactive oxygen species and endothelial function—role of nitric oxide synthase uncoupling and nox family nicotinamide adenine dinucleotide phosphate oxidases,” Basic and Clinical Pharmacology and Toxicology, vol. 110, no. 1, pp. 87–94, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Cortés-Rojo and A. R. Rodríguez-Orozco, “Importance of oxidative damage on the electron transport chain for the rational use of mitochondria-targeted antioxidants,” Mini-Reviews in Medicinal Chemistry, vol. 11, no. 7, pp. 625–632, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. R. Madamanchi and M. S. Runge, “Mitochondrial dysfunction in atherosclerosis,” Circulation Research, vol. 100, no. 4, pp. 460–473, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Lenaz and M. L. Genova, “Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject,” Antioxidants and Redox Signaling, vol. 12, no. 8, pp. 961–1008, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Lorenzo, L. M. Blanco Clio, J. L. Martín Ventura, and E. Sánchez Galán, “Nuevos mediadores implicados en la génesis de la aterosclerosis,” Clínica e Investigación en Arteriosclerosis, vol. 21, no. 1, pp. 25–33, 2009. View at Google Scholar
  15. Y. Higashi, K. Noma, M. Yoshizumi, and Y. Kihara, “Endothelial function and oxidative stress in cardiovascular diseases,” Circulation Journal, vol. 73, no. 3, pp. 411–418, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-J. Lin, S.-K. Shyue, M.-C. Shih et al., “Superoxide dismutase and catalase inhibit oxidized low-density lipoprotein-induced human aortic smooth muscle cell proliferation: role of cell-cycle regulation, mitogen-activated protein kinases, and transcription factors,” Atherosclerosis, vol. 190, no. 1, pp. 124–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. D. Heistad, Y. Wakisaka, J. Miller, Y. Chu, and R. Pena-Silva, “Novel aspects of oxidative stress in cardiovascular diseases,” Circulation Journal, vol. 73, no. 2, pp. 201–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. McCord, “Superoxide dismutase, lipid peroxidation, and bell-shaped dose response curves,” Dose-Response, vol. 6, no. 3, pp. 223–238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Lahera, M. Goicoechea, S. G. de Vinuesa et al., “Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: Beneficial effects of statins,” Current Medicinal Chemistry, vol. 14, no. 2, pp. 243–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Karnovsky and R. C. Graham, “A formaldehide-glutaraldehide fixative of high osmolarity by MET,” The Journal of Cell Biology, vol. 27, pp. 137–138, 1965. View at Google Scholar
  21. O. D. Ratnoff and C. Menzie, “A new method for the determination of fibrinogen in small samples of plasma,” The Journal of Laboratory and Clinical Medicine, vol. 37, no. 2, pp. 316–320, 1951. View at Google Scholar · View at Scopus
  22. S. Moncada and P. Vayanse, “El endotelio y la función cardiovascular,” Cardiovascular Risk Factors, vol. 7, no. 3, pp. 156–161, 1998. View at Google Scholar
  23. J. A. Woolliams, G. Wiener, P. H. Anderson, and C. H. McMurray, “Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep,” Research in Veterinary Science, vol. 34, no. 3, pp. 253–256, 1983. View at Google Scholar
  24. P. M. Vanhoutte, “Endothelial dysfunction—the first step toward coronary arteriosclerosis,” Circulation Journal, vol. 73, no. 4, pp. 595–601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Zhou and J. K. Liao, “Pleiotropic effects of statins. Basic research and clinical perspectives,” Circulation Journal, vol. 74, no. 5, pp. 818–826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Taylor, M. D. Huffman, A. F. Macedo et al., “Statins for the primary prevention of cardiovascular disease,” Cochrane Database of Systematic Reviews, vol. 1, Article ID CD004816, 2013. View at Google Scholar · View at Scopus
  27. T. Sathyapalan, J. Shepherd, S. L. Atkin, and E. S. Kilpatrick, “The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover study,” Diabetes, Obesity and Metabolism, vol. 15, no. 8, pp. 767–769, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. P. S. Silva, R. Lacchini, V. Gomes, and J. T. Santos, “Implicaciones farmacogenéticas de polimorfismos de la eNOS para drogas de acción cardiovascular,” The Journal Arquivos Brasileiros de Cardiologia, vol. 96, no. 2, pp. 27–34, 2011. View at Google Scholar
  29. R. H. Samson and D. G. Nair, “Influence and critique of the JUPITER trial (Statins vs No Statins for primary prevention of cardiovascular events in patients with normal lipids and elevated c-reactive protein),” Seminars in Vascular Surgery, vol. 24, no. 3, pp. 172–179, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Rezzani, F. Bonomini, S. Tengattini, A. Fabiano, and R. Bianchi, “Atherosclerosis and oxidative stress,” Histology and Histopathology, vol. 23, no. 3, pp. 381–390, 2008. View at Google Scholar · View at Scopus
  31. A. Wrzosek, A. Łojek, I. Stanisławska et al., “Endothelial mitochondria—a novel target for pharmacology of endothelial dysfunction,” Postepy Biochemii, vol. 54, no. 2, pp. 198–208, 2008. View at Google Scholar · View at Scopus
  32. S. Itoh, K. Ozumi, H. W. Kim et al., “Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1,” Free Radical Biology and Medicine, vol. 46, no. 1, pp. 95–104, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. L. Neumann, E. G. Schulz, G. C. Hagenah, U. Platzer, E. Wieland, and V. Schettler, “Lipoprotein apheresis—more than just cholesterol reduction?” Atherosclerosis Supplements, vol. 14, no. 1, pp. 29–32, 2013. View at Publisher · View at Google Scholar · View at Scopus